Pfizer pulls out the stops for cancer drugs
Pfizer is set to use this week's high-profile US cancer conference to shine the spotlight on its burgeoning cancer drugs research
Pfizer is set to use this week's high-profile US cancer conference to shine the spotlight on its burgeoning cancer drugs research